Research Article

The Value of Macrogene Second-Generation Sequencing in the Diagnosis, Guidance of Drug Use, and Efficacy Monitoring of Infectious Pneumonia in Premature Infants

Table 2

Analysis and comparison of pathogen physical examination between the two groups (/%).

PathogenObservation group ()Control group ()

Bacteria
 Pseudomonas aeruginosa5 (7.81)5 (13.89)
 Klebsiella pneumoniae10 (15.63)6 (16.67)
 Acinetobacter baumannii8 (12.50)8 (22.22)
 Streptococcus pneumoniae2 (3.13)2 (5.56)
 Staphylococcus aureus5 (7.81)5 (13.89)
 Legionella pneumophila2 (3.13)
 Nocardia1 (1.56)
 Serratia marcescens1 (1.56)1 (2.78)
 Burkholderia cepacia1 (1.56)
Fungus
 Candida albicans5 (7.81)5 (13.89)
 Pneumocystis Yersini8 (12.50)
 Aspergillus fumigatus5 (7.81)4 (11.11)
Virus
 Human spore virus type 11 (1.56)
 Human sporrash virus 52 (3.13)
 Cytomegalovirus1 (1.56)
 Chlamydia psittaci5 (7.81)
 Mycobacterium tuberculosis1 (1.56)
 Mycobacterium Kansas1 (1.56)